Psychocare Health Private Limited is an award-winning company that began its journey in 2013, initially known as Radix Pharmaceuticals (founded in 2005). At PCHPL, our mission is straightforward: to enhance healthcare outcomes while establishing ourselves as the leading PCD pharma franchise company in India. Recognizing the growing demand for neurology and psychiatry medications in India, we specialize in a broad range of neuropsychiatric drugs and offer over 1,200 products across 4 divisions, 3 sister concerns, and a nationwide network of franchisees.
We manufacture and deliver highly effective medications under strict GMP and WHO guidelines. Our turnover for FY 2019-20 was Rs. 27+ crores, and for FY 2020-21, it reached Rs. 33+ crores, with projections for substantial growth in the coming years. Our commitment to innovation, quality, and customer satisfaction has solidified our position in the pharmaceutical industry, making us a reliable partner for pharma franchises, PCD franchises, and pharma PCD franchise opportunities.
We are ISO 9001:2015 certified and GMP-certified. We implement rigorous quality control measures and adhere to superior manufacturing standards to ensure the highest quality in all our products. Our company is dedicated to providing our customers with top-quality PCD products, better stock availability, and competitive pricing.
Dedicated to bringing better healthcare solutions and medicinal facilities, Psychocare Health is always motivated to ensure, enforce, and bring quality drug formulation. As one of the leading neuro pharma PCD companies in Mohali, we are on a mission to provide facilities to patients seeking quality neurology, psychiatric, and cardiac medicines. With vigorous progress in our research development, manufacturing process, and marketing strategies, we are on a path to becoming a leading pharmaceutical company in India.
Flexibility has been an impressive feature of our company, consistently working on improved processes, frequent additions to our product list, clearing marketing deviations, and opening newer opportunities for our associates. We intend to become a globally recognized pharmaceutical company by developing and introducing a broad range of pharmaceutical products, including pharma franchise, PCD franchise, and pharma PCD franchise opportunities. Our skilled team of experts has significantly contributed to raising our efficiency rate. We aim to meet every customer's expectation and work tirelessly to create greater consumer satisfaction.
PCHPL is a certified ISO Pharma company with its very own present-day manufacturing unit. As one of the optimal neuro pharma PCD companies in Mohali, we have an array of tactics in the region to make sure that great manipulation and fine manufacturing requirements are diligently observed. We market our merchandise across India at competitive prices. We aim to lead the pharmaceutical industry by providing high-quality, cost-effective products and establishing a portfolio of affordable medicines accessible to all.
With our clients' non-stop assistance, we intend to reach the pinnacle of India’s neuropsychiatry and cardiac diabetic industry by setting up our presence in each state and district of India. To become a global healthcare organization recognized for our unwavering commitment to innovation, quality, and competence. To establish ourselves as a world-renowned healthcare organization known for our steadfast dedication to competence, quality, and innovation. By offering premium, reasonably priced goods and building a line of accessible medications, we hope to become the industry leader in pharmaceuticals.
On June 29, 2024, this company proudly received the "Best Enterprise of the Year (Pharmaceutical)" 4th award from MSME India Business. The accolade recognizes their dedication to excellence, innovation, and quality.
In 2021-22, our director, Mr Supreet Singh, received the "Brand Impact" award from the Indian Achievers Forum. This award highlights his outstanding influence and leadership in driving the company's success and enhancing its industry presence.
On July 17, 2019, we were honored with the Business Excellence Award from CIMS for our achievements in neuropsychiatric products. This recognition underscores our outstanding contributions and innovation in the field.
Co-Founder and M.D.
Founder and Director
Trusted by 200+ popular brands.